Biocompatibility of elastomeric components. Our commitment to patient safety and regulatory compliance.

The elastomeric formulations developed by Datwyler for healthcare applications are designed to meet stringent biocompatibility requirements, supporting the safety and performance of medical and pharmaceutical products.

As part of our commitment to proactively support our customers and address evolving regulatory expectations, Datwyler has conducted additional biocompatibility evaluations as per updated United States Pharmacopoeia (USP <87>) requirements on a large number of elastomeric formulations. Updated Compound Data Sheets for these formulations, including elution and skin irritation tests in accordance with USP <87>, are available for download on this page.

If you have any difficulties accessing these documents or require additional information, please contact your technical and scientific representative at Datwyler.